MedTrace Logo

Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients

NCT01885065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-06-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.

Conditions

Interventions

OTHER

Gel-based artificial saliva

Gel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth. Taking orally 1-2 teaspoon each time, 5 times / day (30-50 ml/ day) for four weeks.

Sponsors & Collaborators

  • Thammasat University

    collaborator OTHER

  • Srinakharinwirot University

    collaborator OTHER

  • Mahidol University

    collaborator OTHER

  • Ministry of Health, Thailand

    collaborator OTHER_GOV

  • Dental Innovation Foundation Under Royal Patronage

    lead OTHER

Principal Investigators

  • Aroonwan Lam-ubol, DDS, PhD · Faculty of Dentistry, Srinakharinwirot University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885065 on ClinicalTrials.gov